Keyphrases
Clinical Practice Guidelines
100%
Hemodialysis
100%
Kidney Disease Outcomes Quality Initiative (KDOQI)
100%
Dialysis Initiation
100%
Dialysis Duration
100%
Membrane Flux
100%
Dialysis Frequency
100%
Therapy Initiation
42%
Regular Hemodialysis
42%
Dialysis Adequacy
42%
Dialysis Treatment
42%
Cardiovascular Mortality
28%
All-cause Mortality
28%
Early Dialysis
28%
Clinical Outcomes
28%
National Kidney Foundation
28%
Myocardial Infarction
14%
Dialysis
14%
Quality of Life
14%
Blood Pressure
14%
Thrice Weekly
14%
Randomized Clinical Trial
14%
Vascular Access
14%
Hospitalization
14%
Controlled Experiment
14%
Kidney Disease Progression
14%
Group Members
14%
Left Ventricular Mass
14%
Membrane Types
14%
Selection Criteria
14%
Frequency-duration
14%
Vascular Surgery
14%
Antihypertensive Medication
14%
Data Pooling
14%
Cognitive Function Assessment
14%
Timing of Initiation
14%
Life Functioning
14%
Long-term Hemodialysis
14%
Intervention Early
14%
Extended Length
14%
Late Initiation
14%
Dialysis Membrane
14%
Interdialytic Weight Gain
14%
High-flux Dialyzer
14%
Early-late
14%
Estimated Creatinine Clearance
14%
High-flux Membrane
14%
Low-flux Membrane
14%
Nursing and Health Professions
Systematic Review
100%
Practice Guideline
100%
Hemodialysis
100%
Renal Replacement Therapy
21%
Kidney Disease
14%
Clinical Outcome
14%
Vascular Access
14%
Cardiovascular Mortality
14%
All Cause Mortality
14%
Chronic Kidney Failure
7%
Quality of Life
7%
Cerebrovascular Accident
7%
Heart Infarction
7%
Dialysis Membrane
7%
Patient Population
7%
Heart Left Ventricle Mass
7%
Blood Pressure
7%
Antihypertensive Agent
7%
Early Intervention
7%
Creatinine Clearance
7%
Medicine and Dentistry
Systematic Review
100%
Hemodialysis
100%
Renal Replacement Therapy
21%
All Cause Mortality
14%
Nephropathy
14%
Vascular Access
14%
Cardiovascular Mortality
14%
Randomized Clinical Trial
7%
Apoplexy
7%
Quality of Life
7%
Chronic Kidney Disease
7%
Blood Pressure
7%
Patient Population
7%
Myocardial Infarction
7%
Antihypertensive Agent
7%
Controlled Clinical Trial
7%
Creatinine Clearance
7%
Early Intervention
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
All Cause Mortality
14%
Kidney Disease
14%
Cardiovascular Mortality
14%
Controlled Clinical Trial
7%
Randomized Clinical Trial
7%
Heart Infarction
7%
Chronic Kidney Failure
7%
Cerebrovascular Accident
7%
Antihypertensive Agent
7%
Creatinine
7%